Jan 13, 2021 / 08:40PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
All right. We're going to kick it off. Good afternoon. I'm Tycho Peterson. It's my pleasure to introduce our next company this afternoon, Quanterix. Just a quick reminder for folks that want to ask questions to submit them through the website.
With that, let me turn it over to Kevin.
E. Kevin Hrusovsky - Quanterix Corporation - Chairman, President & CEO
Thanks, Tycho. Really excited to be presenting today. This has been a 15-year journey of hiring precision health and trying to understand how the proteomics revolution, we think, can have a very disruptive opportunity to affect and impair a lot of the diseases that are out there. And so today, I'm going to go through these agenda have vision and strategy for disruption and creating value. We're going to talk about our DIFI methodology that we've been deploying that really allows us to have a market-driven vision it's almost like we learn about the killer application. And then we go into various companies, and we evolve
Quanterix Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 14, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers